KR20040092861A - Healthy food composition for accelerating growth - Google Patents
Healthy food composition for accelerating growth Download PDFInfo
- Publication number
- KR20040092861A KR20040092861A KR1020030027282A KR20030027282A KR20040092861A KR 20040092861 A KR20040092861 A KR 20040092861A KR 1020030027282 A KR1020030027282 A KR 1020030027282A KR 20030027282 A KR20030027282 A KR 20030027282A KR 20040092861 A KR20040092861 A KR 20040092861A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- growth
- supplement composition
- health
- health supplement
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000012010 growth Effects 0.000 title claims abstract description 46
- 235000001497 healthy food Nutrition 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000011575 calcium Substances 0.000 claims abstract description 20
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 15
- 230000036541 health Effects 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 5
- 241001474374 Blennius Species 0.000 claims abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 3
- 239000011707 mineral Substances 0.000 claims abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 46
- 230000001737 promoting effect Effects 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 9
- 241000209020 Cornus Species 0.000 claims description 7
- 210000003056 antler Anatomy 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000004576 sand Substances 0.000 claims description 6
- 240000002045 Guettarda speciosa Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 240000006079 Schisandra chinensis Species 0.000 claims description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 3
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- 108010001441 Phosphopeptides Proteins 0.000 abstract description 4
- 239000005018 casein Substances 0.000 abstract description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021240 caseins Nutrition 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 abstract description 4
- 241000628997 Flos Species 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 230000008468 bone growth Effects 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract 2
- 239000010268 Acori graminei Rhizoma Substances 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 230000037257 muscle growth Effects 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 7
- 230000009036 growth inhibition Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 102000018997 Growth Hormone Human genes 0.000 description 5
- 108010051696 Growth Hormone Proteins 0.000 description 5
- 239000000122 growth hormone Substances 0.000 description 5
- 231100000957 no side effect Toxicity 0.000 description 5
- 230000001256 tonic effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000037824 growth disorder Diseases 0.000 description 4
- 210000004349 growth plate Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000208838 Asteraceae Species 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241000509537 Alisma canaliculatum Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 241001609679 Cuscuta japonica Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- YJHVMPKSUPGGPZ-UHFFFAOYSA-N Dihydro-beta-eudesmol Natural products C1CC(C(C)(C)O)CC2C(C)CCCC21C YJHVMPKSUPGGPZ-UHFFFAOYSA-N 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- HXCGUCZXPFBNRD-DNLMCPORSA-N Nodakenin Chemical compound CC(C)([C@@H]1OC2=CC=3OC(=O)C=CC=3C=C2C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HXCGUCZXPFBNRD-DNLMCPORSA-N 0.000 description 1
- HXCGUCZXPFBNRD-QVYYAULWSA-N Nodakenin Natural products O(C(C)(C)[C@@H]1Oc2c(cc3c(OC(=O)C=C3)c2)C1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HXCGUCZXPFBNRD-QVYYAULWSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 101710202017 Protein 1.4 Proteins 0.000 description 1
- 241000282374 Puma concolor Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- XFSVWZZZIUIYHP-UHFFFAOYSA-N beta-Eudesmol Natural products CC(C)(O)C1CCC2CCCC(=C)C2C1 XFSVWZZZIUIYHP-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- BOPIMTNSYWYZOC-VNHYZAJKSA-N beta-eudesmol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(C)(O)C)CC[C@]21C BOPIMTNSYWYZOC-VNHYZAJKSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- ZEASOXUPPLSUSE-UHFFFAOYSA-N butanedioic acid;sulfane Chemical compound S.OC(=O)CCC(O)=O ZEASOXUPPLSUSE-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- GFJIQNADMLPFOW-VNHYZAJKSA-N elemol Chemical compound CC(=C)[C@@H]1C[C@H](C(C)(C)O)CC[C@@]1(C)C=C GFJIQNADMLPFOW-VNHYZAJKSA-N 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- HXCGUCZXPFBNRD-UHFFFAOYSA-N nodakenine Natural products C1C2=CC=3C=CC(=O)OC=3C=C2OC1C(C)(C)OC1OC(CO)C(O)C(O)C1O HXCGUCZXPFBNRD-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/24—Non-sugar sweeteners
- A23V2250/248—Di-Peptides sweeteners
- A23V2250/2482—Aspartam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6422—Xylitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 성장촉진용 건강보조식품 조성물에 관한 것으로, 더욱 상세하게는 인체에 부작용이 없으며, 동시에 성장저해의 요인이 되는 영양의 불균형 등 식품에서 올 수 있는 여러 가지 부족을 보충함으로써 어린이들의 뼈와 근육을 발육을 촉진 및 강화시켜 성장촉진 효과가 뛰어난 성장촉진용 건강보조식품 조성물에 관한 것이다.The present invention relates to a growth-promoting health supplement composition, more specifically, there are no side effects to the human body, and at the same time supplement the various deficiencies that can come from foods such as nutritional imbalance that causes growth inhibition and the bones of children The present invention relates to a growth promoting health supplement composition having an excellent growth promoting effect by promoting and strengthening muscle development.
사람의 성장은 대부분 사춘기까지의 시기에 대부분이 일어나며, 이 시기에 적절한 영양섭취가 이루어지지 않으면 성장이 제대로 이루어지지 않게 된다.Most of human growth occurs until the age of puberty, and if proper nutrition is not achieved at this time, the growth will not be done properly.
성장기 어린이들의 뼈는 성인과는 달리 성장판이 열려있으며, 이 시기에 각종 영양성분의 섭취와 적절한 운동을 통하여 성장판의 부위가 성장하여 전체적으로 키가 커지게 된다.The bones of the growing children, unlike adults, the growth plate is open, at this time through the ingestion of various nutrients and proper exercise, the growth plate area grows overall height.
이와 같은 성장판은 남자의 경우 만16세, 여자의 경우 만14세 정도가 되면 닫히게 되므로 성장기 어린이들은 이 시기에 충분한 영양을 공급하여 성장판의 성장을 도와야 한다.This growth plate will be closed when the age of 16 for men, 14 years of age for women, so growing children should provide enough nutrition at this time to help the growth of the growth plate.
그러나 여러 가지 이유로 인해 이 시기에 적절한 성장이 이루어지지 않는 성장장애가 일어날 수 있으며, 한의학에서는 성장장애의 주된 원인을 신장이 허약하여 성장호르몬(HGH)의 분비와 뼈의 성장이 부진하게 되는 것으로 보고 있다. 따라서, 적절한 시기에 성장호르몬이 충분히 분비되고 촉진할 수 있는 환경과 음식물, 한약재 등의 섭취가 절실히 필요하다.However, for various reasons, growth disorders that do not result in proper growth may occur at this time, and the main cause of growth disorders in Chinese medicine is that kidneys are weak and secretion of growth hormone (HGH) and bone growth are sluggish. . Therefore, it is necessary to ingest the environment and foods, herbal medicines, etc. that can be sufficiently secreted and promoted growth hormone at the appropriate time.
그러나, 현대인들의 식습관이 가공되어진 편리한 음식을 추구하는 경향으로 바뀜으로써 가공과정에서의 미량원소의 소실과 기타 여러 화학 첨가물의 사용으로 우리의 건강에 적지 않은 영향을 주고 있는 실정이다.However, by changing the eating habits of modern people to the tendency to seek processed convenient foods, the loss of trace elements and the use of various chemical additives in the processing process have a significant effect on our health.
따라서 성장기에 성장을 촉진하기 위해서는 기존의 가공식품의 섭취를 줄이고, 균형있는 영양을 섭취함과 동시에 적당한 운동을 하는 것이 필수적이다.Therefore, in order to promote growth in the growth phase, it is essential to reduce the intake of conventional processed foods, eat balanced nutrition and at the same time exercise appropriately.
지금까지 영양의 균형화를 이루기 위하여 많은 성장촉진용 건강식품이 출시되고 있으나, 이들은 단순히 성장을 위하여 도움이 되는 여러 가지 성분들의 조합에만 그침으로써 성장촉진에 많은 효과를 보고 있지 못한 실정이다.Until now, many growth promoting health foods have been released to achieve nutritional balance, but they do not show much effect on growth promotion by merely combining various ingredients that are helpful for growth.
따라서, 성장저해의 요인이 되는 영양의 불균형을 방지하여 어린이들의 성장을 촉진시킬 수 있는 건강보조식품에 대한 연구가 더욱 필요한 실정이다.Therefore, there is a need for further research on health supplements that can promote the growth of children by preventing the imbalance of nutrition that is a factor of growth inhibition.
상기와 같은 종래기술의 문제점을 해결하고자, 본 발명은 성장저해의 요인이되는 영양의 불균형 등 식품에서 올 수 있는 여러 가지 부족을 보충함으로써 어린이들의 뼈와 근육을 발육을 촉진 및 강화시켜 성장촉진 효과가 뛰어난 성장촉진용 건강보조식품 조성물을 제공하는 것을 목적으로 한다.In order to solve the problems of the prior art as described above, the present invention promotes and enhances the growth of bones and muscles of children by supplementing various deficiencies that may come from foods such as nutritional imbalance that causes growth inhibition. An object of the present invention is to provide an excellent growth promoting health supplement composition.
본 발명의 다른 목적은 인체에 부작용이 없으며, 어린이 성장촉진 효과가 우수한 성장촉진용 건강보조식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a growth promoting health supplement composition excellent in children growth promoting effect is not a side effect.
도 1은 본 발명의 일실시예에 따라 제조한 성장촉진용 건강보조식품 섭취 후 신장변화율을 나타낸 그래프이다.1 is a graph showing the rate of change after ingestion of growth-promoting health supplement food prepared according to an embodiment of the present invention.
상기 목적을 달성하기 위하여, 본 발명은 성장촉진용 건강보조식품 조성물에 있어서, 홍화씨 3 내지 7 중량%, 토사자 2 내지 4 중량%, 복분자 2 내지 4 중량%, 백복령 2 내지 4 중량%, 당귀 2 내지 4 중량%, 산수유 2 내지 4 중량%, 목단피 1 내지 3 중량%, 창출 1 내지 5 중량%, 천궁 2 내지 4 중량%, 녹용 0.5 내지 2 중량%, 및 잔량의 택사를 유효성분으로 포함하는 성장촉진용 건강보조식품 조성물을 제공한다.In order to achieve the above object, the present invention, in the growth-promoting health supplement composition, safflower seed 3 to 7% by weight, earth and sand 2 to 4% by weight, bokbunja 2 to 4% by weight, Baekbokyeong 2 to 4% by weight, Angelica 2 To 4% by weight, corn coriander 2 to 4% by weight, 1 to 3% by weight of bark, 1 to 5% by weight, 2 to 4% by weight Cheongung, 0.5 to 2% by weight of antler, and the remaining amount of taxa as an active ingredient It provides a growth promoting health supplement composition.
이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명자들은 성장저해의 요인이 되는 영양의 불균형을 방지하여 어린이들의 성장을 촉진시킬 수 있는 건강보조식품에 대하여 연구하던 중, 홍화씨, 토사자, 복분자, 백복령, 당귀, 산수유, 목단피, 창출, 천궁, 녹용, 및 택사를 유효성분으로 포함하는 건강보조식품 조성물을 제조한 결과, 인체에 부작용이 없으며, 성장기 어린이의 성장촉진에 우수한 효과가 있음을 확인하고, 이를 토대로 본 발명을 완성하게 되었다.The inventors of the present invention while researching health supplements that can promote the growth of children by preventing nutritional imbalances that cause growth inhibition, safflower seed, earth and sand, bokbunja, baekbokyeong, donkey, cornus, velvet skin, creation, cheongung, As a result of preparing a dietary supplement composition comprising antler, and tactile as an active ingredient, it has been confirmed that there is no side effect on the human body, and has an excellent effect on promoting growth of the growing child, and completed the present invention based on this.
본 발명의 성장촉진용 건강보조식품 조성물은 홍화씨 3 내지 7 중량%, 토사자 2 내지 4 중량%, 복분자 2 내지 4 중량%, 백복령 2 내지 4 중량%, 당귀 2 내지 4 중량%, 산수유 2 내지 4 중량%, 목단피 1 내지 3 중량%, 창출 1 내지 5 중량%, 천궁 2 내지 4 중량%, 녹용 0.5 내지 2 중량%, 및 잔량의 택사를 유효성분으로 포함하는 것을 특징으로 한다.Growth promoting health supplement composition of the present invention is 3 to 7% by weight of safflower seed, 2 to 4% by weight of earth and sand, 2 to 4% by weight of bokbunja, 2 to 4% by weight of Baekbokryeong, 2 to 4% by weight, Angelica 2 to 4 It is characterized in that it comprises a weight percent, 1-3% by weight of bark, 1-5% by weight, 2-4% by weight, antler 0.5-2% by weight, and the remaining amount of tackifier as an active ingredient.
본 발명에 사용되는 상기 홍화씨(Flos carthami)는 국화과에 속하는 일년생 화초의 씨앗으로 성장과 골밀도 향상에 도움이 되는 성분을 많이 함유하고 있다. 특히, 홍화씨 내의 백금성분은 뼈 골절 부위에서 양전기과 음전기의 교류작용을 활성화시켜서 백혈구를 골절부분에 집중시킴으로써 뼈를 신속히 재건하고, 생성된 뼈를 강하게 결속시키는 작용을 한다. 또한, 홍화씨 내의 풍부한 칼슘과 구리는 뼈의 경화를 도와서 골밀도 증대에 중요한 작용을 한다.The safflower seed (Flos carthami) used in the present invention is a seed of an annual plant belonging to the Asteraceae, and contains a lot of ingredients that help to improve growth and bone density. In particular, the platinum component in safflower seed activates the alternating action of the positive and negative electrodes at the bone fracture site to concentrate the white blood cells at the fracture site, thereby rapidly rebuilding the bone and strongly binding the generated bone. In addition, abundant calcium and copper in safflower seed help bone hardening and play an important role in increasing bone density.
상기 홍화씨는 건강보조식품 조성물에 3 내지 7 중량%로 포함되는 것이 바람직하다. 그 함량이 3 중량% 미만일 경우에는 그 효과가 저하될 수 있다는 문제점이 있으며, 7 중량%를 초과할 경우에는 소화 장애를 일으킬 수 있으며, 위에 악영향을 미칠 수 있다는 문제점이 있다.The safflower seed is preferably contained in 3 to 7% by weight in the dietary supplement composition. If the content is less than 3% by weight, there is a problem that the effect may be lowered, when it exceeds 7% by weight may cause digestive disorders, there is a problem that may adversely affect the stomach.
본 발명에 사용되는 상기 토사자(Cuscuta japonica Chois.)는 메꽃과에 속하는 한해살이 덩굴성 식물인 새삼의 씨앗으로, 간과 신장을 보호하며 눈을 밝게 해주고, 양기(陽氣)를 도우며 신장 기능을 튼튼하게 해주는 약재로 알려져 있다. 상기 토사자는 뼈를 튼튼하게 해주고, 신장 기능이 허약하여 허리와 무릎이 시리고 아픈 것을 치료하는 작용을 한다.Cuscuta japonica Chois. Used in the present invention is a seed of the annual ginseng, a vine plant belonging to the family Asteraceae, protects the liver and kidneys, brightens the eyes, helps yang (yang), and strengthens kidney function It is known as medicinal herbs. The earth and sand to strengthen the bones, the weak kidney function to act to treat the sore and pain in the lower back and knees.
상기 토사자는 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The earth and sand is preferably contained in 2 to 4% by weight in the dietary supplement composition. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 복분자(Fructus rubi)는 장미과에 속한 낙엽관수인 복분자 딸기 및 동속 근녹식물의 미성숙한 과실로서 뇌하수체에 작용하여 성장호르몬 분비를 왕성하게 하며, 오장육부 기능을 안정화시켜 스트레스를 없애주고, 관절부의 인대, 근육 발육을 원활하게 하는 작용을 한다.The bokbunja (Fructus rubi) used in the present invention acts as an immature fruit of the bokbunja strawberry and the same root green plants of deciduous irrigation belonging to the rosaceae, acting on the pituitary gland to stimulate the growth hormone secretion, stabilizing the five viscera muscle function to eliminate stress It acts to facilitate ligament and muscle development of joints.
상기 복분자는 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The bokbunja is preferably contained in 2 to 4% by weight in the dietary supplement composition. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 백복령(Poria)은 베어 낸 지 여러 해 지난 소나무 뿌리에 기생하여 혹처럼 크게 자란 균핵으로 강장에 효능이 있는 한약재이다. 상기 백복령은 위장, 췌장 등의 소화기능을 촉진시켜 영양분의 흡수를 도우며, 숙면을 취하게 함으로써 불면, 수면 부족으로 인한 성장장애를 없애주어 성장촉진에 도움을 준다.The Baekbokryeong (Poria) used in the present invention is a herb that is effective in tonic as a fungal nucleus that grows largely like a parasite on pine roots that have been cut many years. The baekbokyeong promote digestion of the stomach, pancreas and the like to help the absorption of nutrients, and take a good night's sleep, eliminating the growth disorders caused by lack of sleep helps to promote growth.
상기 백복령은 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The Baekbokyeong is preferably included in the dietary supplement composition 2 to 4% by weight. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 당귀는 여러해살이풀로 Decursin, Decursinol, Nodakenin, α-pinene, Limonene, β-Eudesmol, Elemol 등의 성분을 함유하며, 진정작용, 진경작용, 진통작용, 혈압내림작용, 이뇨작용, 비타민E 결핍증 치료작용,항균작용, 사하작용 등의 약리작용이 있어서 한방치료약으로 사용되며, 뿌리정유의 수용액을 관절염에 쓰면 아픔멎이작용과 소염작용이 있다고 알려져 있다.The Angelica used in the present invention is a perennial herb, contains components such as Decursin, Decursinol, Nodakenin, α-pinene, Limonene, β-Eudesmol, Elemol, sedation, dysfunction, analgesic, blood pressure lowering, diuresis It is used as a herbal remedy because it has pharmacological effects such as vitamin E deficiency treatment, antibacterial action, and hypothalamic action.
상기 당귀는 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The Angelica is preferably contained in 2 to 4% by weight in the dietary supplement composition. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 산수유는 한방에서 보익, 신경쇠약, 음위 등에 약으로 사용된다. 상기 산수유는 간과 신장을 보호하고, 몸을 단단하게 하며, 산수유의 신맛은 근육의 수축력을 높여주고, 허약한 콩팥의 생리기능을 강화하는 작용을 한다.Cornus used in the present invention is used as a medicine in the herbal medicine, such as bowel, nervous breakdown, sonic. The cornus oil protects the liver and kidneys, strengthens the body, and the acidity of the cornus oil increases the contractility of muscles, and acts to strengthen the physiological function of the weak kidney.
상기 산수유는 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The cornus oil is preferably contained in 2 to 4% by weight in the dietary supplement composition. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 목단피는 미나리아재비과의 목단속에 속하며, 목단속의 12 종 중 Paeonia suffruticosa Andrews(=Paeonia moutan Sims)이 약용으로 사용된다. 목단피는 한방에서 소염성 구어혈약으로서 이용되며, 목단의 신선한 근피 중에는 파에놀 배당체인 파에놀사이드 및 파에놀라이드을 함유하고, 이는 조직 중에 있는 가수분해 효소에 의해 파에놀로 분해된다. 상기 파에놀은 항균작용이 있으며, 대장균, 포도상구균, 연쇄상구균, 고초균 등의 증식을 1500~2000 배의 희석 농도에서 억제 작용이 있다. 그 밖에 캄페스테롤, 베타-시토스테롤 등의 성분을 함유하고 있다.The bark of the neck used in the present invention belongs to the tree of the genus Butaria, Paeonia suffruticosa Andrews (= Paeonia moutan Sims) of the 12 species of the tree is used for medicinal purposes. Bark skin is used as an anti-inflammatory gore pill in oriental medicine, and the fresh muscle of the neck contains paenool glycosides, parenosides and paenolides, which are broken down into paenol by hydrolase in the tissues. The paenol has an antibacterial effect, and inhibits the growth of E. coli, Staphylococcus aureus, Streptococcus, Bacillus subtilis, etc. at a diluting concentration of 1500-2000 times. In addition, it contains components such as camphorsterol and beta-sitosterol.
상기 목단피는 건강보조식품 조성물에 1 내지 3 중량%로 포함되는 것이 바람직하다. 그 함량이 1 중량% 미만이거나 3 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The neck skin is preferably contained in 1 to 3% by weight in the dietary supplement composition. If the content is less than 1% by weight or more than 3% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 창출(蒼朮)은 쌍떡잎식물 초롱꽃목 국화과의 여러해살이풀인 삽주(Atractylodes japonica)의 뿌리·줄기 부분으로 발한, 이뇨, 진통, 건위 등에 효능이 있어 식욕부진, 소화불량, 위장염, 감기 등에 사용된다.The creation (창출) used in the present invention is effective in sweating, diuresis, analgesic, dry stomach, etc. as a root and stem part of the perennial herbaceous Atractylodes japonica of the dicotyledon plant Campanula Asteraceae, anorexia, dyspepsia, gastroenteritis Used for colds, etc.
상기 창출은 건강보조식품 조성물에 1 내지 5 중량%로 포함되는 것이 바람직하다. 그 함량이 1 중량% 미만이거나 5 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The creation is preferably contained in 1 to 5% by weight in the dietary supplement composition. If the content is less than 1% by weight or more than 5% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 천궁(Cnidium officinale)은 방향성 식물로 한방에서는 뿌리·줄기 부분을 진정, 진통, 강장 등에 효능이 있어 두통, 빈혈증, 부인병 등에 사용한다.The uterus (Cnidium officinale) used in the present invention is an aromatic plant that is effective in soothing, analgesic, tonic, root, stem, etc., in oriental medicine, used for headache, anemia, gynecological diseases and the like.
상기 천궁은 건강보조식품 조성물에 2 내지 4 중량%로 포함되는 것이 바람직하다. 그 함량이 2 중량% 미만이거나 4 중량%를 초과할 경우에는 성장촉진 효과가 미미하다는 문제점이 있다.The cheongung is preferably included in the dietary supplement composition 2 to 4% by weight. If the content is less than 2% by weight or more than 4% by weight, there is a problem that the growth promoting effect is insignificant.
본 발명에 사용되는 상기 녹용은 보정강장약(補精强壯藥)으로 사용된다. 상기 녹용은 부드러운 세모(細毛)로 덮여 있으며 혈관이 많이 들어 있으며 칼슘이 풍부하다. 녹용은 간기능을 보호하며, 조혈기능을 강화하는 작용을 하며, 항원에 대한 항체 생산을 촉진시키며 체내에서 항원, 항체 복합체를 형성함으로써 빠르게 항원을 중화시켜 생체를 보호하는 작용을 한다. 특히 세포성 면역과 체액성 면역을모두 증강시키고, 내분비계의 발달을 촉진시켜서 성장을 촉진시키는 작용을 한다.The antler used in the present invention is used as a correction tonic (補 精 强壯 藥). The antler is covered with soft hairs (細毛), contains a lot of blood vessels and is rich in calcium. Deer Antler protects liver function, strengthens hematopoietic function, promotes antibody production against antigens, and forms neutralizing antigens and antibody complexes in the body to quickly neutralize antigens to protect living organisms. In particular, it enhances both cellular and humoral immunity, and promotes the development of the endocrine system to promote growth.
상기 녹용은 건강보조식품 조성물에 0.5 내지 2 중량%로 포함되는 것이 바람직하다. 그 함량이 0.5 중량% 미만일 경우에는 그 효과가 저하될 수 있다는 문제점이 있으며, 2 중량%를 초과할 경우에는 소화 장애를 일으킬 수 있으며, 위에 악영향을 미칠 수 있다는 문제점이 있다.The antler is preferably contained in 0.5 to 2% by weight in the dietary supplement composition. If the content is less than 0.5% by weight there is a problem that the effect may be lowered, if it exceeds 2% by weight may cause digestive problems, there is a problem that may adversely affect the stomach.
본 발명에 사용되는 상기 택사(Alisma canaliculatum)는 외떡잎식물 소생식물목 택사과의 여러해살이풀로 한방에서 뿌리·줄기 부분이 이뇨제, 수종, 임질 등에 약으로 사용된다.As used in the present invention, the Taxa (Alisma canaliculatum) is a perennial herb of a monocotyledonous reproductive plant Taxa, which is used as a diuretic, a species, gonorrhea, etc.
본 발명의 건강보조식품 조성물은 상기와 같은 성분을 동시에 함유함으로써 각각의 성분이 상보적인 작용을 나타내어 어린이 성장촉진의 효과를 더욱 상승시킬 수 있게 된다.The health supplement composition of the present invention by containing the above components at the same time each component exhibits a complementary action it is possible to further increase the effect of the child growth promotion.
또한 본 발명의 건강보조식품 조성물은 상기의 성분 이외에 석창포, 숙지황, 산약, 오미자, 건강, 작약, 백삼, 산사자, 산조인, 감초, 또는 녹각 등의 한약재 성분을 추가로 포함할 수 있으며, 상기 추가로 포함되는 한약재 성분은 본 발명의 건강보조식품 조성물의 유효성분의 효과를 더욱 향상시키는 작용을 한다.In addition to the above components, the health supplement food composition of the present invention may further include herbal ingredients such as Seokchangpo, succinate sulfur, cauliflower, Schisandra chinensis, health, peony, white ginseng, hawthorn, sanjoin, licorice, or green tea. Herbal medicine ingredients are included to further enhance the effect of the active ingredient of the health supplement composition of the present invention.
상기 한약재 성분 중 석창포는 천남성과에 딸린 늘푸른 여러해살이 풀로 톡 쏘는 듯한 독특한 향을 내는데, 바로 이 향기 성분이 뇌를 튼튼하게 하고 기억력을 좋게 하며, 마음을 안정시키고 아픔을 멎게 하는 작용을 한다. 상기 석창포는 뇌신경의 피로를 풀어주는데 우수한 효과가 있다.Among the herbal ingredients, Seokchangpo has the unique fragrance of green perennial herb attached to Cheonnam Province, and this fragrance ingredient acts to strengthen the brain and improve memory, to stabilize the mind and to soothe pain. The Seokchangpo has an excellent effect to relieve fatigue of the cranial nerves.
상기 숙지황은 여러해살이풀로 뿌리를 지황이라 하는데 짜고 말리기를 아홉번 거듭한 것을 숙지황(熟地黃) 또는 숙변(熟卞)이라 한다. 상기 숙지황은 보혈 강장 강정제로 사용된다.The sulfur is a perennial grass roots called jihwang, but nine times the squeeze and dry it is called Sujeongjihwang (Maturity 地 黄) or Suk Byeon (Mature). Sukji sulfur is used as a blood tonic tonic.
상기 한약재 성분 각각은 건강보조식품 조성물 100 중량부에 대하여 0.1 내지 25 중량부로 포함되는 것이 바람직하다. 그 함량이 0.1 중량부 미만일 경우에는 그 효과가 저하될 수 있다는 문제점이 있으며, 25 중량부를 초과할 경우에는 소화 장애를 일으킬 수 있으며, 위에 악영향을 미칠 수 있다는 문제점이 있다.Each of the herbal ingredients is preferably contained in 0.1 to 25 parts by weight based on 100 parts by weight of the health supplement composition. If the content is less than 0.1 parts by weight there is a problem that the effect may be lowered, if it exceeds 25 parts by weight may cause digestive disorders, there is a problem that may adversely affect the stomach.
상기와 같은 생약재 또는 한약재 성분은 각각의 선별된 생약제 또는 한약제를 분말화하고, 이들 성분을 혼합함으로써 얻을 수 있으며, 통상의 배합 기술을 이용하여 제조할 수 있다.The herbal or herbal medicine components as described above can be obtained by pulverizing each selected herbal medicine or herbal medicine and mixing these components, and can be prepared using conventional compounding techniques.
또한 본 발명의 건강보조식품 조성물은 상기의 성분 이외에 성장에 필수적인 칼슘을 추가로 포함할 수 있다.In addition, the health supplement composition of the present invention may further include calcium necessary for growth in addition to the above components.
상기 칼슘은 해조칼슘 또는 패각칼슘을 사용할 수 있으며, 특히 홍조류에서 추출한 해조칼슘을 사용하는 것이 바람직하다. 해조칼슘은 식품성 칼슘성분으로 다른 칼슘에 비해 칼슘의 입자가 작아 흡수율이 높고, 흡수를 방해하는 섬유질, 피트산(phytic acid), 및 수산(oxalic acid)을 함유하지 않는다.The calcium may be used algae calcium or shell calcium, it is particularly preferred to use algae calcium extracted from red algae. Algae calcium is a food-based calcium component, calcium particles are smaller than other calcium, the absorption rate is high, and does not contain fiber, phytic acid, and oxalic acid which interfere with absorption.
상기 칼슘은 건강보조식품 조성물 100 중량부에 대하여 100 내지 500 중량부로 포함되는 것이 바람직하다. 그 함량이 100 중량부 미만일 경우에는 그 효과가 저하될 수 있다는 문제점이 있으며, 500 중량부를 초과할 경우에는 소화 장애를 일으킬 수 있으며, 위에 악영향을 미칠 수 있다는 문제점이 있다.The calcium is preferably contained in 100 to 500 parts by weight based on 100 parts by weight of the health supplement composition. If the content is less than 100 parts by weight there is a problem that the effect may be lowered, if it exceeds 500 parts by weight can cause digestive disorders, there is a problem that may adversely affect the stomach.
또한 본 발명의 건강보조식품 조성물은 상기 성분 이외에 미량의 미네랄, 비타민, 또는 단백질 등을 추가로 포함할 수 있다.In addition, the dietary supplement composition of the present invention may further include a trace mineral, vitamin, or protein in addition to the above components.
상기 미네랄은 마그네슘, 아연, 철, 불소, 망간, 또는 요오드 등의 성장기에 필요한 영양성분을 사용할 수 있으며, 상기 비타민은 비타민 효모, 비타민 C, 비타민 E, 또는 비타민 D3등을 사용할 수 있으며, 상기 단백질은 옥수수 단백 추출물 분말 또는 아미노산 펩타이드를 사용할 수 있다.The mineral may be used for nutrients necessary for the growing season, such as magnesium, zinc, iron, fluorine, manganese, or iodine, the vitamin may be used vitamin yeast, vitamin C, vitamin E, or vitamin D 3 , The protein may use corn protein extract powder or amino acid peptide.
본 발명의 건강보조식품 조성물은 상기 칼슘의 흡수를 촉진하기 위한 보조 성분으로 카제인포스포펩타이드(caseinphosphopeptide, CPP)를 건강보조식품 조성물 100 중량부에 대하여 0.1 내지 1 중량부로 추가로 첨가할 수 있으며, 이외에 포도맛 분말, 자일리톨, 프락토올리고당, 아스파탐 등을 첨가할 수도 있다.The dietary supplement composition of the present invention may be added to the casein phosphopeptide (casein phosphopeptide, CPP) in an amount of 0.1 to 1 parts by weight based on 100 parts by weight of the dietary supplement composition as an auxiliary component for promoting the absorption of calcium, In addition, grape flavor powder, xylitol, fructooligosaccharide, aspartame and the like may be added.
상기와 같은 성분으로 이루어지는 본 발명의 성장촉진용 건강보조식품 조성물은 인체에 부작용이 없으며, 성장저해의 요인이 되는 영양의 불균형 등 식품에서 올 수 있는 여러 가지 부족을 보충함으로써 어린이들의 뼈와 근육을 발육을 촉진 및 강화시켜 성장촉진 효과가 우수한 장점이 있다.Growth promotion health supplement composition of the present invention made of the above ingredients has no side effects on the human body, and supplements various deficiencies that may come from foods such as nutritional imbalance that causes growth inhibition, thereby reducing the bones and muscles of children The growth promoting effect is excellent by promoting and strengthening the growth.
상기와 같은 성분으로 포함하는 본 발명의 건강보조식품 조성물에 함유되는 성분은 모두 식품재료 및 식품으로 사용되는 것으로, 복용 또는 섭취시 인체에 대한 안전성이 우수하다. 상기 건강보조식품은 통상의 제조방법에 따라 분말, 캡슐, 산제, 정제, 과립, 탕제, 엑기스, 음료 등의 형태로 제형화할 수 있다.All components contained in the health supplement food composition of the present invention containing the above components are used as food ingredients and foods, it is excellent in safety to the human body when taking or ingesting. The dietary supplement may be formulated in the form of powder, capsule, powder, tablet, granule, powder, extract, beverage and the like according to a conventional manufacturing method.
본 발명의 건강보조식품 조성물은 연령, 체중에 따라 적량을 선택하여 섭취할 수 있으며, 1일 1200 내지 2400 ㎎의 섭취로 충분한 성장 효과를 얻을 수 있다.상기 섭취량은 1회 또는 2회 이상으로 나누어 복용할 수 있으며, 바로 씹어서 먹거나, 물이나 우유와 같이 섭취하여도 좋다.The dietary supplement composition of the present invention may be ingested by selecting a suitable amount according to age and weight, and sufficient growth effect may be obtained by ingesting 1200 to 2400 mg per day. The intake is divided into one or two or more times. You can take it, chew it right away, or take it with water or milk.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다.Hereinafter, preferred examples are provided to help understanding of the present invention, but the following examples are merely to illustrate the present invention, and the scope of the present invention is not limited to the following examples.
[실시예]EXAMPLE
실시예 1Example 1
산지에서 채취, 엄선하여 세척하고, 이물질을 제거한 후 건조시킨 생약제를 분쇄하여 분말화하였다. 상기 분말화한 생약제와 기타 성분을 하기 표 1의 배합 비율에 균일하게 혼합한 후, 통상의 방법에 따라 타정하여 정제를 제조하였다. 상기 제조한 정제의 영양성분을 분석하여 하기 표 2에 나타내었다.Collected from the mountain area, carefully selected and washed, and remove the foreign matter, the dried herbal medicine was pulverized and powdered. The powdered herbal medicine and other ingredients were uniformly mixed in the blending ratio of Table 1, and then compressed into tablets according to a conventional method. To analyze the nutritional components of the prepared tablets are shown in Table 2.
실시예 2Example 2
먼저 25∼30 g의 BALB/C 쥐를 10 마리씩 두 그룹으로 나누어 준비하여 실험 전에 12 시간 절식시켰다. 한 그룹에는 상기 실시예 1에서 제조한 정제를 쥐에게경구투여하고, 다른 그룹은 대조군으로 동일량의 먹이를 섭취시켰다.First, 25-30 g of BALB / C mice were prepared in two groups of 10 rats and fasted 12 hours before the experiment. In one group, the tablets prepared in Example 1 were orally administered to rats, and the other group received the same amount of food as a control.
쥐를 6 개월 동안 성장시킨 후 외관상으로 발육정도를 관찰한 결과, 두 그룹 모두 외관상의 부작용은 확인되지 않앗으며, 건강한 활동을 유지하는 것을 확인할 수 있었다.After growing the rats for 6 months, the apparent developmental results showed that both groups had no apparent side effects and maintained healthy activity.
또한 상기 실시예 1에서 제조한 정제를 투여시킨 그룹의 쥐를 4 마리 선별하여 간을 적출한 후, 간조직을 검사한 결과 이상 증후를 발견하지 못하였다.In addition, four mice of the group to which the tablets prepared in Example 1 were administered were screened for liver extraction, and liver tissue was examined, and no abnormal symptoms were found.
실시예 3Example 3
성장기의 청소년을 남녀 구별없이 20 명을 선정하여 상기 실시예 1에서 제조한 정제를 1일 3회 식후 3 정씩 물과 함께 섭취하는 방법으로 6 개월 동안 복용시켰다. 이 후 체지방 및 신장을 측정하고, 그 결과를 도 1 및 하기 표 3에 나타내었다. 또한, 상기 정제 섭취 이후 부작용이나 기타 특별한 증후는 별견되지 않았으며, 이로부터 상기 실시예 1에서 제조한 정제가 인체에 안정함을 알 수 있었다.Adolescents in the growing stage were selected for 20 men and women regardless of gender, and the tablets prepared in Example 1 were taken for 6 months by taking 3 tablets three times a day with water after meals. After that, body fat and height were measured, and the results are shown in FIG. 1 and Table 3 below. In addition, no side effects or other special symptoms after ingestion of the tablets were not found, from which the tablets prepared in Example 1 were found to be stable to the human body.
실시예 4Example 4
성장장애가 있는 성장기의 청소년을 남녀 구분없이 50 명을 대상으로 상기 실시예 1에서 제조한 정제를 1일 2회 식후 10 알씩 물과 함께 섭취하는 방법으로 6 개월 동안 복용시켰다. 상기 복용 대상의 성장호르몬 분비량을 매월 측정한 결과,평균 10 %의 성장호르몬 분비의 증가를 보였으며, 최고 14 %까지 증가함을 확인할 수 있었다.Adolescents with growth disorders were taken for 6 months by ingesting tablets prepared in Example 1 with 10 tablets twice a day with water, regardless of gender. As a result of measuring monthly growth hormone secretion of the subjects, the growth hormone secretion was increased by an average of 10%, and it was confirmed that the increase was increased up to 14%.
본 발명에 따른 성장촉진용 건강보조식품 조성물은 인체에 부작용이 없으며, 성장저해의 요인이 되는 영양의 불균형 등 식품에서 올 수 있는 여러 가지 부족을 보충함으로써 어린이들의 뼈와 근육을 발육을 촉진 및 강화시켜 우수한 성장촉진 효과가 있다.The growth promoting health supplement composition according to the present invention has no side effects on the human body, and promotes and strengthens the development of bones and muscles of children by supplementing various deficiencies that may come from foods such as nutritional imbalance that causes growth inhibition. Excellent growth promoting effect.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0027282A KR100509983B1 (en) | 2003-04-29 | 2003-04-29 | Healthy food composition for accelerating growth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0027282A KR100509983B1 (en) | 2003-04-29 | 2003-04-29 | Healthy food composition for accelerating growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20040092861A true KR20040092861A (en) | 2004-11-04 |
| KR100509983B1 KR100509983B1 (en) | 2005-08-25 |
Family
ID=37373189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-2003-0027282A KR100509983B1 (en) | 2003-04-29 | 2003-04-29 | Healthy food composition for accelerating growth |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100509983B1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100715653B1 (en) * | 2006-04-21 | 2007-05-09 | 박승만 | Growth-promoting foodstuff |
| KR100731160B1 (en) * | 2006-05-26 | 2007-06-22 | 최영진 | Crude drugs composition for accelerating recovery of bone fracture |
| KR101376052B1 (en) * | 2012-04-19 | 2014-03-19 | 주식회사 한미양행 | The foodstuff composition comprising the extract of Rubus coreanus Miquel or ethyl acetate fraction therefrom for bone growth- promoting |
| KR101493442B1 (en) * | 2014-01-13 | 2015-02-16 | 하성미 | The extracts concentrate of medical herbs for promoting children and youths growth and method for fabricating the same |
| WO2016137085A1 (en) * | 2015-02-25 | 2016-09-01 | 주식회사 진용 | Food composition for promoting bone length growth and increasing bone density, containing safflower seed extract, boswellia extract and scutellaria baicalensis extract as active ingredients |
| KR102013847B1 (en) * | 2019-04-30 | 2019-08-23 | (주)펜즈 | Composition for promoting growth of height comprising Humulus japonica Sidb. et Zucc. component as an active ingredient and health functional foods comprising the same |
| KR20230000530A (en) * | 2021-06-24 | 2023-01-03 | 광동제약 주식회사 | Composition for promoting growth of height comprising extracts of Cervus Parvum Cornu |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101456127B1 (en) * | 2013-07-04 | 2014-11-03 | 윤희송 | A composition for increasing bone growth |
| KR102058868B1 (en) * | 2019-01-09 | 2019-12-26 | 조경하 | Herbal composition for promoting growth and improving eye health and herbal medicine preparation using same |
-
2003
- 2003-04-29 KR KR10-2003-0027282A patent/KR100509983B1/en not_active IP Right Cessation
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100715653B1 (en) * | 2006-04-21 | 2007-05-09 | 박승만 | Growth-promoting foodstuff |
| KR100731160B1 (en) * | 2006-05-26 | 2007-06-22 | 최영진 | Crude drugs composition for accelerating recovery of bone fracture |
| KR101376052B1 (en) * | 2012-04-19 | 2014-03-19 | 주식회사 한미양행 | The foodstuff composition comprising the extract of Rubus coreanus Miquel or ethyl acetate fraction therefrom for bone growth- promoting |
| KR101493442B1 (en) * | 2014-01-13 | 2015-02-16 | 하성미 | The extracts concentrate of medical herbs for promoting children and youths growth and method for fabricating the same |
| WO2016137085A1 (en) * | 2015-02-25 | 2016-09-01 | 주식회사 진용 | Food composition for promoting bone length growth and increasing bone density, containing safflower seed extract, boswellia extract and scutellaria baicalensis extract as active ingredients |
| KR102013847B1 (en) * | 2019-04-30 | 2019-08-23 | (주)펜즈 | Composition for promoting growth of height comprising Humulus japonica Sidb. et Zucc. component as an active ingredient and health functional foods comprising the same |
| US11759489B2 (en) | 2019-04-30 | 2023-09-19 | Pens Co., Ltd. | Food composition for promoting height growth and pharmaceutical composition for promoting height growth including Humulus japonicus extract or ground Humulus japonicus as active ingredient |
| KR20230000530A (en) * | 2021-06-24 | 2023-01-03 | 광동제약 주식회사 | Composition for promoting growth of height comprising extracts of Cervus Parvum Cornu |
Also Published As
| Publication number | Publication date |
|---|---|
| KR100509983B1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100472052B1 (en) | Cosmetic composition using fermentation of natural herb medicine | |
| CN101856430A (en) | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof | |
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN103585261A (en) | Maca ginseng tablet and preparation method thereof | |
| CN104873763A (en) | Health-care product for conditioning Qi deficiency constitution | |
| CN103191332A (en) | Composition and health-care product with stomach-invigorating and digestion-promoting functions | |
| KR100509983B1 (en) | Healthy food composition for accelerating growth | |
| CN1077861A (en) | Health eggs | |
| CN110151983A (en) | A kind of Chinese materia medica preparation and preparation method thereof for tonifying Qi of the kidney | |
| KR100800359B1 (en) | A composition having depilation preventing and trichogenousness effect | |
| CN105533233A (en) | Traditional Chinese medicine feed formula for preventing and treating parasitic diseases of poultry | |
| KR20130009901A (en) | Health food composition for improving blood circulation, strengthening energy and preventing osteoporosis | |
| KR20100077781A (en) | Method for preparing functional powder to improve erectile dysfunction and assistance food comprising the functional powder | |
| CN102058775B (en) | Health-care pressure-lowering tea and preparation method thereof | |
| CN109498704A (en) | A kind of raising immunity, the composition for dispelling moisture and its preparation method and application | |
| KR100278206B1 (en) | Health supplement composition for growth | |
| KR100376305B1 (en) | Healthy food composition for protecting hepatic | |
| JP2004321087A (en) | Healthy food and method for producing the same | |
| CN111758809A (en) | Astragalus membranaceus and samara leaf health-care tea | |
| KR20070107393A (en) | Composition for promotion of growth | |
| CN1321667C (en) | Capsule sheep extractive for protecting, strengthening health and preserving youth | |
| KR20190116045A (en) | Method for producing medicine of growth lack | |
| CN109479824A (en) | A kind of production method rich in element egg of enriching blood | |
| CN106901012A (en) | A kind of selenium-rich Radix Astragali sow feed additive and preparation method thereof | |
| CN105815453A (en) | Whitening and beautifying soybean milk powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20120710 Year of fee payment: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20130827 Year of fee payment: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20140729 Year of fee payment: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20150728 Year of fee payment: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20160808 Year of fee payment: 12 |
|
| LAPS | Lapse due to unpaid annual fee |